Phase II Study Commences for Terumo's Anaconda Stent Graft System

 

June 19, 2009—The Arizona Heart Institute in Phoenix announced that Julio Rodriguez-Lopez, MD, performed the first procedure in the phase II study of the Vascutek Anaconda stent graft system (Terumo Cardiovascular Systems, Ann Arbor, MI) for the endovascular treatment of abdominal aortic aneurysms (AAAs). Dr. Rodriguez-Lopez is the study's national principal investigator. The objective of the phase II study, conducted under an investigational device exemption, is to assess the safety and efficacy of the Anaconda system in patients presenting with AAAs when compared to historical open-surgical repair. The study is expected to enroll a total of 180 patients at 20 sites in the United States.

"The Anaconda stent graft system has the potential to treat patients with infrarenal AAAs," commented Dr. Rodriguez. "In commercial use outside the US phase II study, this stent graft has been shown to be flexible and repositionable. These are important features when treating patients with infrarenal AAAs."
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.